| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC | VP, HEAD OF RESEARCH | Common Stock | 193,923 | $166,774 | $0.8600 | 25 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 24 Aug 2024 | 2 | -$1,029 | 4 | VP, HEAD OF RESEARCH | 27 Aug 2024, 16:38 |
| SGMO | SANGAMO THERAPEUTICS, INC | 24 May 2024 | 2 | -$717 | 4 | VP, HEAD OF RESEARCH | 29 May 2024, 17:00 |
| SGMO | SANGAMO THERAPEUTICS, INC | 24 Feb 2024 | 2 | -$5,275 | 4 | VP, HEAD OF RESEARCH | 27 Feb 2024, 17:14 |
| SGMO | SANGAMO THERAPEUTICS, INC | 22 Jan 2024 | 1 | $0 | 4 | VP, HEAD OF RESEARCH | 24 Jan 2024, 16:42 |
| SGMO | SANGAMO THERAPEUTICS, INC | 25 Nov 2023 | 1 | -$187 | 4 | VP, Head of Research | 28 Nov 2023, 16:15 |
| SGMO | SANGAMO THERAPEUTICS, INC | 20 Nov 2023 | 0 | $0 | 3 | VP, Head of Research | 28 Nov 2023, 16:14 |